Skip to main content

Peer Review reports

From: Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

Original Submission
25 Oct 2015 Submitted Original manuscript
4 Feb 2016 Reviewed Reviewer Report - Lekha Pandit
10 Feb 2016 Reviewed Reviewer Report - Vijayshree Yadav
3 Mar 2016 Reviewed Reviewer Report - Daniel M Harrison
15 Apr 2016 Author responded Author comments - Ralf Gold
Resubmission - Version 2
15 Apr 2016 Submitted Manuscript version 2
22 Jun 2016 Author responded Author comments - Ralf Gold
Resubmission - Version 3
22 Jun 2016 Submitted Manuscript version 3
Publishing
12 Jul 2016 Editorially accepted
26 Jul 2016 Article published 10.1186/s12883-016-0635-y

You can find further information about peer review here.

Back to article page